Bicycle Therapeutics (BCYC) Stock Chart & Stock Price History $7.39 -0.10 (-1.34%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$7.37 -0.02 (-0.27%) As of 04/17/2025 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Bicycle Therapeutics Stock Price Performance 5 Day Performance+4.53%1 Month Performance-22.62%3 Month Performance-44.60%6 Month Performance-72.66%Year-To-Date Performance-47.21%1 Year Performance-68.49% Receive BCYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bicycle Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address BCYC Stock Chart for Sunday, April, 20, 2025 BCYC Chart by TradingView Bicycle Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2025$7.39$7.39$7.50$7.29144,647 shs$511.40 million04/17/2025$7.49$7.39-1.34%$7.50$7.29144,647 shs$511.40 million04/16/2025$7.79$7.49-3.85%$7.80$7.45305,423 shs$518.32 million04/15/2025$7.07$7.79+10.18%$8.00$6.97649,748 shs$539.08 million04/14/2025$6.70$7.07+5.52%$7.19$6.58410,253 shs$489.26 million04/11/2025$6.53$6.70+2.60%$6.85$6.40595,528 shs$463.65 million04/10/2025$6.88$6.53-5.09%$6.82$6.38250,335 shs$451.89 million04/09/2025$6.38$6.88+7.84%$6.98$6.101.10 million shs$476.11 million04/09/2025$6.38$6.88+7.84%$6.98$6.101.10 million shs$476.11 million04/08/2025$6.75$6.38-5.48%$7.28$6.31377,310 shs$441.51 million Get the Latest News and Ratings for BCYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bicycle Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025$6.75$6.38-5.48%$7.28$6.31377,310 shs$441.51 million04/07/2025$6.89$6.75-2.03%$7.09$6.27517,687 shs$467.11 million04/04/2025$7.43$6.89-7.27%$7.41$6.77352,845 shs$476.80 million04/03/2025$8.05$7.43-7.70%$7.90$7.41432,351 shs$514.17 million04/02/2025$7.85$8.05+2.55%$8.25$7.80456,772 shs$557.08 million04/01/2025$8.49$7.85-7.54%$8.42$7.85418,321 shs$543.24 million03/31/2025$8.97$8.49-5.35%$8.90$8.20458,263 shs$587.53 million03/28/2025$9.19$8.97-2.39%$9.55$8.89278,673 shs$620.74 million03/27/2025$8.73$9.19+5.27%$9.69$9.00500,397 shs$635.97 million03/26/2025$8.85$8.73-1.36%$9.10$8.60302,855 shs$604.13 million03/25/2025$9.20$8.85-3.80%$9.44$8.75241,947 shs$612.44 million03/24/2025$9.08$9.20+1.32%$9.35$8.88702,669 shs$636.66 million03/21/2025$9.49$9.08-4.32%$9.67$9.08258,785 shs$628.35 million03/20/2025$9.55$9.49-0.63%$9.86$9.35137,814 shs$656.73 million03/19/2025$9.57$9.55-0.21%$9.94$9.44167,083 shs$660.88 million03/18/2025$9.98$9.57-4.11%$9.90$9.35345,103 shs$660.77 million Related Companies Mirum Pharmaceuticals Stock Chart Schrödinger Stock Chart Denali Therapeutics Stock Chart Metsera Stock Chart Biohaven Stock Chart Tarsus Pharmaceuticals Stock Chart Belite Bio Stock Chart NewAmsterdam Pharma Stock Chart Ascentage Pharma Group International Stock Chart Janux Therapeutics Stock Chart Receive BCYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bicycle Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BCYC) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicycle Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicycle Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
